The import substitution policy has been actively implemented as a way to address the sanctions since 2014. From then on, the state procurement area has been changed repeatedly, as its legal regulation allows for various restrictive and prohibitive tools to be used as a flexible system of incentives for Russian suppliers. Owing to the crisis caused by the COVID-19 pandemic it has again become a priority to support domestic manufacturers.
The crisis has made sharper the need for a more efficient use of antimonopoly measures in cases where violations have been committed in socially important spheres such as pharmaceuticals and healthcare. The bad-faith conduct of actors in these markets has become an especially sensitive matter against the backdrop of the severe situation with the coronavirus epidemic. The Russian Federal Antimonopoly Service is closely watching such violations caused by a soaring need for specific categories of goods and services.